18 May 2013
Keywords: sucampo, takeda, sign, ibs, drug, deal, pharmaceuticals
Article | 08 November 2004
Sucampo Pharmaceuticals of the USA and Japan's Takeda have entered into a collaboration and license agreement for the former's lubiprostone. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 November 2004
18 April 2005
17 May 2013
© 2013 thepharmaletter.com